Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 7, 2023Journal of NeurologyOpen Access

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

View Full Paper
Ask AI
Bookmark
Share

Authors

TKTania KümpfelKGKatrin GiglhuberOAOrhan Aktaş

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kümpfel et al. (2023) studied this question.

synapsesocial.com/papers/6a7df77ba76b9ebabb045d84https://doi.org/10.1007/s00415-023-11910-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Open-label, add-on trial of cetirizine for neuromyelitis optica2018 · 26 citations
  2. 2Treatment of neuromyelitis optica: state-of-the-art and emerging therapies2014 · 267 citations
  3. 3Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica2011 · 256 citations
  4. 4Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis2020 · 18 citations